Singapore markets closed

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.61+0.26 (+2.78%)
At close: 04:00PM EDT
9.61 0.00 (0.00%)
After hours: 05:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close9.35
Bid9.61 x 800
Ask10.21 x 1400
Day's range9.24 - 10.11
52-week range5.60 - 19.32
Avg. volume1,107,223
Market cap746.933M
Beta (5Y monthly)1.06
PE ratio (TTM)N/A
EPS (TTM)-2.75
Earnings date07 Nov 2022 - 11 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est19.63
  • Zacks

    Here's Why Coherus BioSciences (CHRS) Looks Ripe for Bottom Fishing

    Coherus BioSciences (CHRS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

  • Zacks

    Wall Street Analysts Think Coherus BioSciences (CHRS) Could Surge 47%: Read This Before Placing a Bet

    The average of price targets set by Wall Street analysts indicates a potential upside of 47.3% in Coherus BioSciences (CHRS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

  • Motley Fool

    Coherus BioSciences (CHRS) Q2 2022 Earnings Call Transcript

    This release can be found on the Coherus BioSciences website and is also attached to our Form 8-K. Today's call includes forward-looking statements regarding Coherus' current expectations about future events. All these forward-looking statements involve substantial risks and uncertainties that are beyond our control and could cause actual results, performance or achievements to differ from results, performance or achievements implied by the forward-looking statements.